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Dopaminergic neurotransmission has been highly implicated in the reinforcing properties of many substances of abuse, including
marijuana.Cannabinoidsactivateventraltegmentalareadopaminergicneurons,themainascendingprojectionsofthemesocorticolim-
bic dopamine system, and change their spiking pattern by increasing the number of impulses in a burst and elevating the frequency of
bursts. Although they also increase time-averaged striatal dopamine levels for extended periods of time, little is known about the
temporal structure of this change. To elucidate this, fast-scan cyclic voltammetry was used to monitor extracellular dopamine in the
nucleus accumbens of freely moving rats with subsecond timescale resolution. Intravenous administration of the central cannabinoid
(CB1)receptoragonist,R()-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-(1-naphthalenyl)
methanone mesylate, dose-dependently produced catalepsy, decreased locomotion, and reduced the amplitude of electrically evoked
dopamine release while markedly increasing the frequency of detected (nonstimulated) dopamine concentration transients. The CB1
receptor antagonist [N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide] reversed and pre-
ventedallagonist-inducedeffectsbutdidnotshoweffectsondopaminereleasewheninjectedalone.Thesedatademonstratethatdoses
ofacannabinoidagonistknowntoincreaseburstfiringproduceongoingfluctuationsinextracellulardopamineonapreviouslyunrec-
ognizedtemporalscaleinthenucleusaccumbens.
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Introduction
Midbraindopaminergicneuronsnormallyfireatlowfrequencies
of 5–10 Hz in freely moving rats, with periodic short bursts of
high-frequencyactivity(20Hz)thatbecomemoreprevalentin
response to salient stimuli (Hyland et al., 2002). Indeed, burst
firing of dopamine (DA) neurons has been shown to be of func-
tional significance in the context of sensory processing, specifi-
callywithregardtoreward(Schultz,1998).Increasesintheburst
rate of dopaminergic neurons produce greater peak extracellular
dopamine concentrations at axon terminals (Gonon, 1988;
Wightmanetal.,1988;OvertonandClark,1997).Recently,rapid
surges in extracellular dopamine concentration or “transients”
have been observed with fast-scan cyclic voltammetry at carbon-
fiberelectrodesimplantedinvariousterminalfields(Robinsonet
al., 2002) that would be consistent with bursting activity of do-
paminergic neurons. The transients only last for a few seconds
andcanbetime-lockedtospecificreward-relatedbehaviorssuch
as cocaine self-administration (Phillips et al., 2003) and operant
responding for natural rewards (Roitman et al., 2004) during
which they appear to promote reward-seeking.
Drugs of abuse share the ability to increase dopamine neuro-
transmission in the nucleus accumbens (NAc) (Di Chiara and
Imperato, 1988; Nestler, 2002; Wise, 2002). Some abused drugs
such as amphetamine and cocaine have direct actions on dopa-
minergic neurons, whereas others such as the main psychoactive
component of marijuana, 
9-tetrahydrocannabinol (
9-THC)
(Mechoulam and Gaoni, 1967), exert their actions indirectly. In-
deed, 
9-THC exerts its reinforcing effects primarily via an ac-
tion on central cannabinoid (CB1) receptors, the endogenous
ligands of which are arachidonic acid derivatives such as anand-
amide and 2-arachidonyl-glycerol (Freund et al., 2003). This en-
dogenous system interacts with many neurotransmitters in the
brain, including GABA, glutamate, and acetylcholine; however,
cannabinoid receptors are not found on dopaminergic neurons
(Herna `ndezetal.,2000).Nevertheless,extracellulardopaminein
the NAc is elevated by 
9-THC or synthetic CB1 agonists as
shown by microdialysis studies (Chen et al., 1991; Tanda et al.,
1997; Tanda and Goldberg, 2003).
A possible mechanism explaining this increase in NAc extra-
cellular dopamine would be an indirect excitatory action of can-
nabinoids on ventral tegmental area (VTA) dopaminergic neu-
rons, the main ascending dopaminergic projection to the NAc.
Indeed, in the VTA-containing slice, CB1 agonists enhance the
firing rate of dopaminergic neurons in a nondesensitizing man-
ner (Cheer et al., 2000a) via a reduction of afferent GABAergic
transmission (Szabo et al., 2002). This finding is consistent with
the anatomical distribution of CB1 receptors and has added the
VTA to a number of brain regions in which cannabinoids are
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mann,2001).Cannabinoidsgivenatdosesthatelevatedopamine
levels in the NAc also excite dopaminergic neurons in the VTA
through CB1 receptors in vivo (French et al., 1997; Gessa et al.,
1998; Cheer at al., 2003). Furthermore, VTA dopamine neurons
in anesthetized or paralyzed rats exhibit an elevated number of
action potentials within bursts after cannabinoid application
(French, 1997; Diana et al., 1998; Wu and French, 2000).
In this work we used fast-scan cyclic voltammetry in freely
movingratstomeasuretheeffectsofsystemicadministrationofa
cannabinoidagonistatdosesreportedtoincreasephasicfiringof
VTAdopamineneuronstodeterminewhethertime-resolveddo-
pamine release events that are functionally relevant can be ob-
served after cannabinoid treatment. The effect of the agonist on
extracellular dopamine was manifested as an increase in the fre-
quency and amplitude of periodic dopamine transients, suggest-
ing that changes in dopamine release dynamics follow a
cannabinoid-induced enhancement of burst (phasic) activity in
dopaminergic neurons.
MaterialsandMethods
Animals and surgery. Male Sprague Dawley rats (n  21) implanted with
a jugular vein catheter (250–350 gm; Charles River, Wilmington, MA)
were housed individually in clear plastic cages with ad libitum access to
food and water on an inverted 12 hr light/dark cycle. After 1 week, ani-
mals were anesthetized with xylazine hydrochloride (10 mg/kg, i.p.) and
ketamine hydrochloride (100 mg/kg, i.p.) for implantation of electrodes
for voltammetry as described previously (Robinson et al., 2002). Briefly,
a guide cannula (BAS, West Lafayette, IN) aimed at the NAc core (1.3
mm anterior and 1.3 mm lateral relative to bregma) was permanently
affixed to the skull, and a bipolar stimulating electrode (Plastics One,
Roanoke, VA) was lowered to the medial forebrain bundle (MFB) (4.2
mm posterior, 1.4 mm lateral, and 8.6 mm ventral from the brain sur-
face). A Ag/AgCl reference electrode was positioned in the contralateral
hemisphere. Once stimulated dopamine release was voltammetrically
detected in the ipsilateral NAc core with a carbon-fiber electrode, the
stimulatingelectrodeandguidecannulawerepermanentlyaffixedtothe
skullwiththeaidofmachinescrewsandcranioplasticcement.Ratswere
allowed to regain their presurgical weight (at least 48 hr postoperative)
before freely moving experiments were initiated. All animal protocols
and care were approved by the Institutional Animal Care and Use Com-
mittee of the University of North Carolina at Chapel Hill.
Fast-scancyclicvoltammetry.Cylindricalcarbon-fibermicroelectrodes
with an exposed tip of 50–100 m were prepared by pulling capillary
glass (A-M Systems, Carlsborg, WA) around carbon fibers (T650, 6 m
diameter; Amoco Corporation, Greenville, SC). A fresh electrode was
lowered each day to the core of the NAc (6–8 mm, ventral) with the aid
ofamicrodrivethatlockedtotheimplantedguidecannula.Ahead-stage
cablewasconnectedtotheelectrodeassembly,andanimalsweretethered
to a rotating commutator situated in the top of the experimental cham-
ber, which allowed for virtually unrestrained movement. The carbon-
fiber electrode was held at 0.4 V versus Ag/AgCl between scans and
thendrivento1.3Vandbackinatriangularmannerat400V/secevery
100 msec. This waveform is similar to that documented previously that
produces enhanced sensitivity for dopamine (Heien et al., 2003). The
waveform was generated and current was monitored with an interface
board (National Instruments, Austin, TX) in a Pentium IV computer
running custom-designed LABVIEW (National Instruments) software.
Medial forebrain stimulations consisted of 24 biphasic pulses (2 msec,
125 A per phase) delivered at 60 Hz/min to elicit dopamine release.
Behavioraltesting.Spontaneouslocomotoractivitywasmonitoredus-
ingaDigiScanAnimalActivityMonitor(AccuScanInstruments,Colum-
bus,OH).Asetoffiveinfrared(IR)beams3cmabovethefloorofthebox
were used to determine locomotor activity. Ten readings of horizontal
activity were obtained every minute for 10 min. Because animals were
tested multiple times in 1 d and cannabinoids are known to suppress
locomotion, each rat was exposed for 10 min to the locomotor activity
box before testing to avoid a habituation confound. Catalepsy was eval-
uated with an 8 mm diameter metal bar suspended 10 cm above the
floor of the cage by two wooden blocks 20 cm apart. Both forepaws
were placed on the bar, and the time the animal kept them on the bar
before both limbs returned to the ground was recorded (Wu et al.,
2000). The average time from three identical trials in each rat was
recorded. Trials were terminated after 180 sec.
Data analysis. Cyclic voltammograms (used for identification of de-
tected species) were background subtracted from 10 cyclic voltammo-
grams obtained before the stimulation to remove the capacitive and
charging currents. To examine all of the detected voltammetric events
duringarecordingperiod,two-dimensionalplotswereusedwithtimeas
theabscissa,triangularwavevoltageastheordinate,andthebackground
subtracted current encoded in false color. The temporal profile of volta-
mmetrically detected dopamine changes was obtained by plotting the
current at the peak oxidation of dopamine (600 mV vs Ag/AgCl) as a
function of time. To remove contributions from ionic changes that fre-
quently accompany stimulated dopamine release (Venton et al., 2003),
currents measured at a potential at which only ionic changes occurred
were adjusted in amplitude and subtracted from current at the peak
potential for dopamine oxidation (Phillips and Wightman, 2003). Simi-
lardatatreatmentwasusedfordopaminecalibration(1M)experiments
in a flow injection system used after freely moving experiments.
Cyclic voltammograms were collected into 1 min data files. An MFB
stimulation to evoke dopamine release occurred at 30 sec within the
collection interval. A background-subtracted cyclic voltammogram of
the dopamine detected at the end of the stimulation in each animal was
used as a template for identification of dopamine during other times in
the recording interval. Typical noise levels were equivalent to 13 nM
dopamine;onlysignalslargerthanthiswereconsideredforanalysis.The
entire file was evaluated for dopamine transients by taking a moving
average of 10 scans and subtracting it from a cyclic voltammogram re-
corded 1 sec later. The resultant cyclic voltammogram was compared
with the template voltammogram, and a correlation coefficient was ob-
tained. The event was termed dopaminergic only if the correlation coef-
ficient was 0.75. To obtain such a correlation coefficient, the cyclic
voltammogram needed to have peaks that occurred at approximately
600and200mVversusAg/AgCl(oxidationandreductionpotentials
characteristic of dopamine). In addition, dopamine transients were re-
quired to meet these criteria for at least two consecutive scans.
GraphswereconstructedfromthedatausingGraphPadPrism(Graph
Pad Software, San Diego, CA). The amplitudes of stimulated dopamine
releaseinfilessurroundingdruginjectionswereanalyzedwithrespectto
pre-drugvalueswithconventionalANOVAandScheffeposthoctests;the
criterion of significance was set at p  0.05. Drug-induced effects on
spontaneous dopamine transients were determined by averaging the
numberofdopaminetransientsin1minfilesbeforeandaftertheadmin-
istrationofdrugs.StatisticalanalysesusedSTATISTICA(StatSoft,Tulsa,
OK). Data are expressed as mean  SEM.
Drugs. R()-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo
[1,2,3-DE]-1,4-benzoxazin-6-yl]-(1-naphtmalenyl)methanone mesylate
(WIN55,212–2)(WIN)(Sigma,St.Louis,MO,USA)and[N-piperidino-
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-car-
boxamide](SR141716A)(SR)(ResearchTriangleInstitute–NationalIn-
stitute on Drug Abuse, Raleigh, NC) were freshly suspended in a 1:1:18
ratio of ethanol, emulphor (Alkamuls EL-620, Rhodia, Cranbury, NJ),
and heparinized saline (0.9%) for intravenous injection. Initially, rats
(n  9) received the following dosing protocol (separated by at least 15
minforalldosingregimens):vehicle(200l),WIN(125and250g/kg),
SR (300 g/kg), and WIN again (250 g/kg). To test the involvement of
the endogenous cannabinoid system in the regulation of fast dopamine
release, rats (n  4) were given vehicle (200 l) followed by SR (300
g/kg) and WIN (250 g/kg). The last experiment evaluated the dose-
dependence of WIN-induced effects; animals (n  8) were given intra-
venousbolusdosesofvehicle(200l)followedbyWINatdosesof25,50,
and 75 g/kg, yielding a cumulative dose of 150 g/kg. Time-matched
controls received saline injections.
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Electricallyevokedandspontaneousdopaminereleasein
freelymoving rats
Electrical stimulation of the MFB with parameters that rats will
readily self-administer (Garris et al., 1999) evokes dopamine re-
lease in the NAc of a freely moving rat that can be monitored by
fast-scan cyclic voltammetry (Garris et al., 1997) (Fig. 1A). A
representative recording obtained after adjusting the position of
the carbon-fiber electrode for optimal response to dopamine is
shown in Figure 1A. Detection of dopamine during and after the
stimulation(Fig.1A,deliveredduringtheredbarabovethecolor
plot) is indicated by its oxidation current encoded as a green
circlecenteredat600mV,accompaniedbyitsreversecurrentat
200 mV encoded by the dark blue circle (Michael et al., 1999).
A cyclic voltammogram extracted from the data at the end of the
stimulation(firstverticalline)isidenticaltothatfordopaminein
vitro (Fig. 1B). Longer-lasting changes in current with a peak at
225mV(darkblue)areseenafteruptakeofdopamine.Acyclic
voltammogram extracted at this later time (indicated by the sec-
ond vertical line) has the characteristics of an alkaline pH shift,
characterized previously in anesthetized animals (Fig. 1B) (Ven-
ton et al., 2003a). The current at 600 mV (Fig. 1A, x) can be
corrected for these ionic changes (Fig. 1A, y) to reveal the time
course of dopamine release and uptake.
Anotherdopamineconcentrationtransientisalsoapparentin
this record at the time indicated by the asterisk in Figure 1A.I t
precedes the electrical stimulation and was not associated with
any overt stimulus. The correlation coefficient obtained by com-
parison of its cyclic voltammogram (Fig. 1B) with that obtained
during the electrical stimulation was 0.77, indicating that it is
caused by dopamine. This transient had a maximal amplitude of
32 nM, considerably less than the electrically evoked response
(521nM)inthisexample.Spontaneousdopaminetransientssuch
as this were observed in the NAc in nine of nine rats, with an
average frequency of 1.4  0.4 min
-1.
ThecannabinoidagonistWIN55,212–2enhancesdopamine
transientsbutdepresseselectricallyevoked release
Immediately after systemic administration of the cannabinimi-
metic WIN given at a dose of 125 g/kg, a short-lived increase in
ambulation (4 sec) followed by the onset of a cataleptic state
Figure1. SpontaneousandelectricallyevokeddopaminereleaseintheNAcmonitoredby
cyclicvoltammetry.A,Thevoltammetriccurrent(encodedincolor)isplottedagainsttheap-
pliedpotential(ordinate)andtheacquisitiontime(abscissa).Duringelectricalstimulationof
the MFB (biphasic pulses, 0.4 sec duration, 60 Hz, 120 A; red bar), dopamine rapidly in-
creased(greenspotshowsoxidativecurrent).Thedarkblueareaafterthegreenspotiscaused
by a nondopaminergic (ionic) change. The time courses of the signals observed at different
appliedpotentials(indicatedbythedashedwhitelines)areshowntotherightofthecolorplot:
x,currentatthepeakoxidationpotential(0.62V)fordopamine;y,currentat0.21V,apotential
insufficienttooxidizedopaminebutcenteredontheionicchange.Subtractionofyfromxyields
asignalthatisattributabletodopaminechanges;redboxesaretimesatwhichelectricalstim-
ulationbeganandended;asteriskidentifiesthedopaminetransient.B,Cyclicvoltammograms
extractedfromthisdataset:EvokedDA,thecyclicvoltammogramrecordedattheendofthe
stimulation;DAtransient,thecyclicvoltammogramrecordedatthetimeindicatedbytheas-
teriskonthecolorplot;r
2,thecorrelationcoefficientforthecomparisonofthetwovoltammo-
grams.Thecyclicvoltammogramcharacteristicoftheionicchange(atthetimeofthesecond
verticaldashedbaronthecolorplot)isshowntotheright.
Figure2. WIN55,212–2increasesthenumberofdopamineconcentrationtransientsinthe
NAc. Cyclic voltammograms recorded in the same animal and location as in Figure 1 after
administrationofWIN(125g/kg).Thetraceabovethecolorplotisthecurrentatthepotential
wheredopamineisoxidized,correctedforionicchanges.Asterisksindicatetimesatwhichcyclic
voltammograms reveal an increase in dopamine concentration. Electrical stimulation of the
MFB(biphasicpulses,0.4secduration,60Hz,120A)occurredatthetimeindicatedbythe
redbar.Thecyclicvoltammogramcorrespondingtostimulatedrelease(redbar)inthebottom
panel (solid line) exhibits a correlation coefficient of 0.93 when superimposed on the WIN-
inducedtransient(dashedline)occurringimmediatelybeforeit.
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(San ˜udo-Pen ˜a et al., 2000). Voltammetric responses during the
cataleptic phase are shown in Figure 2. The data are from the same
animal and recording site as in Figure 1. The number of dopamine
transients in the recording interval was enhanced simultaneously
with the onset of changes in locomotion (five transients after WIN
compared with one before drug for this particular example over the
30 sec shown). The bottom panel shows the cyclic voltammograms
obtained after MFB electrical stimulation (solid line) and a cyclic
voltammogram corresponding to the WIN-induced dopamine
transient(correlationcoefficientof0.93)thatoccurredimmediately
before the stimulation (dashed line).
Timecourseofcannabinoid-inducedchangesinphasic
dopamine neurotransmission
After injection of WIN [WIN first dose (WIN1): 125 g/kg] and
the onset of catalepsy, two events occurred: the number of con-
firmed dopamine transients increased and remained elevated for
atleast3minafterinjection,andtheevokedreleaseofdopamine
was greatly reduced immediately after administration of WIN
(WIN1: 125 g/kg). Before drug administration, electrical stim-
ulations (indicated by black lines) repeated at 1 min intervals
evoked a similar maximal dopamine concentration (Fig. 3). In
the time between the stimulated responses, noise and some do-
paminetransients(indicatedbytheasterisks)areseen.Themax-
imal concentration of stimulated dopamine release was dimin-
ished immediately after drug administration, but electrically
evoked release of dopamine exhibited a tendency to return to
pre-drug values 2 min after injection (Fig. 3).
When examined across animals (n  9), the maximal dopa-
mineevokedbyelectricalstimulationwassignificantlydecreased
from47892nM(pre-drug)to16154nM(WIN1:125g/kg)
(F(10,425)  3.59; p  0.005). The maximal concentration of DA
evoked by electrical stimulation is attributable to the balance
between uptake and release (Wightman et al., 1988). Analysis of
the disappearance of dopamine after stimulation revealed that
thediminishedresponsewasnotcausedbyanincreaseintherate
ofuptake.Indeed,therateofdopamineclearancewasunchanged
asshowninFigure4,inwhichtheuptakeportionsoftheaverage
dopamine responses obtained before and after drug administra-
tion (WIN1: 125 g/kg; n  9 for each condition) are overlaid.
Statisticalanalysisoftheslopesofdopamineclearancebeforeand
after WIN administration revealed no significant differences
(F(60,1302)0.32;p0.95;interactiontimetreatment).There-
fore, we conclude that the decreased maximal dopamine evoked
by electrical stimulation after WIN is caused by a decrease in the
amount released.
When evaluated in multiple animals, the increase in number
of dopamine transients after WIN administration was found to
besignificant.Overall,thefrequencyofpre-drugdopaminetran-
sients before and after WIN (WIN1: 125 g/kg) was enhanced
Figure 3. Time course of change in dopamine transients after WIN55,212–2. Dopamine
concentrationsextractedfromcyclicvoltammogramsasinFigure2butrecordedovera6min
interval. The rat was administered WIN (125 g/kg), which induced catalepsy at the time
indicated.DopaminereleasewasevokedwithoneMFBstimulationperminute(biphasicpulses,
0.4secduration,60Hz,120A;blackbars).Asterisksbetweentheevokedresponsesindi-
catepeaksthatwereidentifiedasdopaminebycyclicvoltammetry.
Figure 4. Lack of effect of WIN55,212–2 on dopamine uptake in freely moving rats. The
descendingportionsoftheevokeddopaminesignalsbeforeandafterWINadministration(125
g/kg) are overlaid. Five evoked responses were averaged for each treatment. Data were
time-shiftedsothattheinitialdopamineconcentrationwas0.73Mineachcase(n3).
Figure5. WIN55,212–2increasestheamplitudeofdopamineconcentrationtransientsde-
tectedintheNAc.Histogramdistributionsoftheamplitudeofdopaminetransients(WIN1:125
g/kg;n9).Binsizeis50nM.
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-1 (F(10,503)  11.99;
p0.0001).Thespontaneousfrequencyintheabsenceofdrugis
greater than we reported previously, but in that work a lower
sensitivityapproachwasusedandsometransientsmayhavebeen
missed (Robinson et al., 2002). The amplitude distribution of
dopamine transients before and after WIN showed that the can-
nabinoid agonist increased the amplitude of the dopamine tran-
sients (Fig. 5). Pre-drug spontaneous transients had a mean am-
plitude of 51.1  9.2 nM, whereas after WIN (WIN1: 125 g/kg)
they increased to 98.7  22.6 nM ( p  0.01; Student’s t test),
causing a rightward shift in the distribution. This effect was not
observed after injection of vehicle in which the mean amplitude
of transients was 47.1  12.2 nM ( p  0.23; Student’s t test).
TheactionsofWIN55,212–2aremediatedthrough
CB1 receptors
When given to rats rendered cataleptic by WIN [WIN second
dose (WIN2): 250 g/kg], SR (300 g/kg), a CB1 receptor antag-
onist, reverted the catalepsy and animals regained their righting
reflex and resumed exploratory behavior within 10 sec after ad-
ministration. The antagonist also reversed both the WIN-
induced increase in the rate of dopamine transients and the sup-
pressionofelectricallyevokeddopaminerelease.Administration
of SR abolished high-amplitude transients, and mean transient
amplitude in the presence of SR was shifted to 60.5  13.1 nM,
which was not significantly different from pre-drug ( p  0.09;
Student’s t test). A representative example from a different rat is
shown in Figure 6, in which the example in the third panel was
collected immediately after the injection of SR.
Pooled data from multiple animals administered a series of
doses of WIN and SR confirm the significance of these changes.
Althoughadministrationofvehicledidnotchangetheamplitude
ofstimulatedrelease([DA]max)(Fig.7A)orthenumberofdopa-
mine transients (Fig. 7B), administration of WIN (WIN1: 125
g/kg)significantlysuppressed[DA]maxandincreasedthenum-
ber of transients. A subsequent dose (WIN2: 250 g/kg) did not
alter either parameter further. SR reversed both effects of WIN
and prevented further changes by a subsequent injection of WIN
(WIN2: 250 g/kg) (Fig. 7A,B).
A separate group of rats (n  4) was given SR after vehicle to
test whether transient dopamine release was controlled tonically
by endocannabinoids. The antagonist (300 g/kg) prevented the
appearance of catalepsy and blocked the enhancing effects of
WIN (WIN2: 250 g/kg) on the rate of dopamine transients, but
had no effects when injected alone as shown in Figure 7C.
WIN55,212–2dose-dependentlymodifiesbehaviorand
subseconddopamine release
Thedose-dependenceofWINondopaminereleaseandtheonset
of the well documented changes in movement that cannabinoids
caninducewasevaluated(n8)(San ˜udo-Pen ˜aetal.,2000).The
frequency of spontaneous dopamine transients increased in a
dose-dependent manner (Fig. 8A) and reached statistical signif-
icance after the last intravenous infusion of WIN (75 g/kg) of
thedosingprotocol(F(3,140)3.82;p0.05;cumulativedoseof
150 g/kg). Additionally, electrically stimulated dopamine re-
lease exhibited a trend to diminish, but this effect did not reach
significance (F(3, 152)  1.71; p  0.16) (Fig. 8B). To allow for
drug clearance, the effects on locomotion were evaluated in the
samerats72hrlater.Ratsweregiventhesamedosingprotocolat
thesametimeofday.Locomotionwasexquisitelysensitivetothe
treatment with WIN (black bars) because even the lowest dose
(25 g/kg) significantly lowered the number of IR beam breaks
(134.4  8.9) compared with vehicle (184.1  11.6). Higher
doses(50and75g/kg)furtherdepressedlocomotion(F(3,156)
34.26;p0.001)(Fig.8C).Catalepsywasalsodose-dependently
Figure 6. Changes in dopamine neurotransmission after WIN55,212–2 are reversed by
SR141716A. Left panel, Spontaneous dopamine transients (asterisk) and dopamine release
evokedbyelectricalstimulationoftheMFB(biphasicpulses,0.4secduration,60Hz,120A;
blackbar).Centerpanel,Dopaminechangesmonitoredinthe1minintervalafteradministra-
tionofWIN(125g/kg).Notethatelectricallyevokedreleaseisreducedby50%.Theright
traceshowsthereversaloftheseeffectsbySR(300g/kg).
Figure 7. Mean responses of dopamine to a cannabinoid agonist and antagonist. A, The
maximal dopamine concentration ([DA]max) elicited by electrical stimulation of the MFB is
decreased after the first injection of WIN (125 g/kg; WIN1) but not further decreased by a
largerdose(250g/kg;WIN2).ThiseffectisreversedandpreventedbySR(300g/kg;SR;
&p0.05comparedwithWIN2),andasubsequentinjectionofWIN(250g/kg;WIN2)does
not affect this (**p  0.005 compared with vehicle; n  9 rats). B, The frequency of NAc
dopamine concentration transients (n  9 rats) induced by an initial injection of WIN (125
g/kg; WIN1) and a subsequent one (250 g/kg; WIN2). SR (300 g/kg; SR) reversed the
effectsofWINandblockedfurthereffectsofWIN(250g/kg;WIN2).(***p0.001compared
withpre-drug).C,AdministrationofSR(300g/kg;SR)doesnotaffectthefrequencyofdopa-
minetransients(n4rats)butpreventschangesbyWIN(250g/kg;WIN2).Ineachpanel,
vehicleconsistsofa1:1:18ethanol/emulphor/saline(0.9%)ratio.Bolusdoseswereeachspaced
by15min.
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cancecomparedwithvehicleattheintermediatedoseof50g/kg
andwasfurtherincreasedwiththelastdoseof75g/kg(F(3,44)
9.25; p  0.001). No significant effects on locomotion or cata-
lepsy were observed when saline (Fig. 8C,D, white bars) was ad-
ministered to drug-naive rats (n  4) at similar intervals.
Discussion
Thisstudyaddressestheroleofcannabinoidsonrapiddopamine
neurotransmission. Although microdialysis studies have shown
that cannabinoids increase dopamine over minutes (Chen et al.,
1991; Tanda et al., 1997, 1999), the temporal structure of this
changeisnotknown.HereweconfirmthatthepotentCB1recep-
tor agonist, WIN55,212–2, increases extracellular dopamine but
reveal that this is manifested as an increase in the frequency and
amplitudeofrapiddopaminetransientsintheNAc.Theseeffects
are dose-dependent and reversed by the central cannabinoid re-
ceptor antagonist, SR141716A, indicating that they are receptor
mediated.
The actions of WIN do not appear to involve altered dopa-
mine uptake, as shown by unchanged clearance rates after stim-
ulated release. Indeed, they are unlikely to be mediated in the
NAc because cannabinoids applied directly to dopaminergic ter-
minalsinNAcbrainslicesdonotaffectevokeddopaminerelease
(Szabo et al., 1999); however, cannabinoids do produce an in-
crease in the overall firing rate of dopaminergic neurons in the
VTA(French,1997;Frenchetal.,1997;Cheeretal.,2000a,2003;
Szabo et al., 2002). An augmentation in the burst-firing rate of
dopaminergic neurons could increase the amplitude of transient
dopamine release because, when neurons shift to a bursting pat-
tern, the resulting action potentials cause greater extrasynaptic
levels of transmitter compared with the same number of equally
spaced action potentials at a lower frequency (Gonon and Buda,
1985; Gonon, 1988; Wightman et al., 1988). The failure of SR to
alter the rate of dopamine transients concurs with electrophysi-
ological findings that show no effect on the endogenous firing of
VTA dopaminergic neurons (French, 1997; Cheer et al., 2003).
Thesefindingssuggestthatunderbasalphysiologicalconditions,
endogenous cannabinoid tone is not sufficient to modify neuro-
nal activity in the VTA.
Cannabinoidsareknowntoexerttheireffectspresynaptically,
via CB1 receptors located mainly on GABAergic and glutamater-
gicterminals(SchlickerandKathmann,2001;WilsonandNicoll,
2002). Consistent with previous reports, WIN dose-dependently
decreased spontaneous locomotion and produced marked cata-
lepticeffects(San ˜udo-Pen ˜aetal.,2000;WileyandMartin,2003).
In this study, rats displayed vocalizations and aggressiveness to-
ward handling when cataleptic (San ˜udo-Pen ˜a et al., 2000). The
dose–response experiment indicates that changes in locomotion
precede the observed effects on dopamine release, which were
detected when the dosing was sufficient to produce a loss of the
righting reflex. Cataleptic doses of cannabinoids are also known
to induce conditioned place aversion (San ˜udo-Pen ˜a et al., 1997;
Cheeretal.,2000b).Inhumans,catatonia,characterizedbymus-
cularrigidityaccompaniedbyintensefear,isreportedafterwith-
drawal from benzodiazepines (Rosebush and Mazurek, 1995),
whichisassociatedwithareductioninGABAtone(San ˜udo-Pen ˜a
et al., 2000). These findings suggest that the cannabinoid-
induced cataleptic state, accompanied by dysphoria, arises by
diminishing GABAergic function. Presynaptic inhibition of
GABA release is consistent with the current findings because do-
paminergic neurons receive a strong GABAergic input in the
VTA (Ikemoto and Panksepp, 1999; Szabo et al., 2002). In addi-
tion, a recent report by Melis et al. (2004) shows that WIN also
inhibits excitatory synaptic transmission within the VTA. This
findingmayexplainwhycannabinoidagonistscanelicitincreases
as well as decreases (albeit in a smaller population) in the firing
rateofextracellularlyrecordedVTAneurons(Cheeretal.,2003),
indicating that the generation of dopamine transients may re-
quire reciprocal actions on VTA neurons.
Dopamine transients in the NAc have been detected previ-
ously with cyclic voltammetry at carbon-fiber electrodes. They
occurspontaneouslywhenananimalisinsolitudeintheabsence
of any overt stimuli and without any obvious behavioral re-
sponse.Theybecomemorefrequentinresponsetosalientstimuli
suchaspresentationofaconspecific(Robinsonetal.,2002).They
also occur in response to cues that are associated with cocaine
taking (Phillips et al., 2003) or with natural rewards (Roitman et
al., 2004), during which they appear to promote reward-seeking.
Interestingly, the doses of WIN that elicit dopamine transients
have independently been shown to alter cocaine self-
administration (Fattore et al., 1999), suggesting that cannabi-
noids exert their effects on goal-directed behavior by modifying
dopamine release on a temporal scale relevant to the coding of
discreet behavioral events. The neural basis for these concentra-
tion transients has yet to be unraveled, although they have a
striking similarity in time course to dopamine release evoked by
rapidtrainsofstimuluspulsesthatmimicburstfiring.Moreover,
the dopamine transients arise with regularity similar to that of
low bursting activity rates of dopaminergic neurons in freely
moving rats (Hyland et al., 2002). Because transients rapidly di-
minish in concentration as they diffuse from their release site
(Venton et al., 2003b), this rapid form of chemical communica-
Figure8. Dose-dependenteffectsofWIN55,212–2ondopaminereleaseandbehavior.For
allpanelsvehicle[1:1:18,ethanol/emulphor/saline(0.9%)ratio],2525g/kg,5050
g/kg,and7575g/kg(n4rats).Intravenousbolusdoseswerespacedby15min.A,
FrequencyofdopamineconcentrationtransientsintheNAcduringacumulativedosingregi-
men (*p  0.05). B, The maximal dopamine concentration ([DA]max) elicited by electrical
stimulationoftheMFB.Theresponsetendstodecreasewiththecumulativedosingregimenbut
was not significant at any dose. C, Locomotor activity after treatment with WIN. Black bars
represent WIN-treated animals, whereas time-matched, saline controls are depicted with
white bars. (***p  0.001 compared with vehicle;
&&&p  0.001 compared with time-
matchedsalinecontrol;
&&p0.005comparedwithtime-matchedsalinecontrol).D,Admin-
istrationofWINdose-dependentlyincreasescatalepsyasmeasuredusingthebartest(*p
0.05,***p0.001comparedwithvehicle;
&&&p0.001comparedwithtime-matchedsaline
control).
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The increase in the frequency and amplitude of dopamine
transients in this study was accompanied by a decrease in the
concentration of electrically evoked dopamine, demonstrating
that the amount of dopamine released per impulse was dimin-
ished. Electrically evoked dopamine release was similarly de-
pressed in freely moving rats after doses of ethanol that cause
elevated extracellular dopamine as measured by microdialysis
(Budyginetal.,2001).There,weproposedthatevokeddopamine
release was reduced because of increased spontaneous release re-
sulting from the documented increased neuronal activity of do-
paminergic neurons caused by ethanol (Gessa et al., 1985). Be-
cause of the increased sensitivity of the voltammetric technique
used in this work (Heien et al., 2003), we were able to directly
measure an increase in spontaneous dopamine transients after
cannabinoid administration that may underlie the depression of
evokeddopamine.Indeed,thereductioninstimulateddopamine
release seen after both of these drugs is consistent with suppres-
sion of the amount of dopamine released per impulse after peri-
ods of sustained activity (Montague et al., 2004). Assuming that
the transients are a result of burst firing, an increase in their
amplitude,despitediminishedreleaseperimpulse,wouldrequire
agreaternumberofimpulsestobepresentineachburst.Accord-
ingly,electrophysiologicalstudiesinVTAdopaminergicneurons
have shown that CB1 receptor agonists do produce such an in-
crease in action potentials per burst (French, 1997; Gessa et al.,
1998).
Overall, this study contributes to the growing body of evi-
dencethatdopaminetransientsareamajorformofcommunica-
tion in the NAc by this neurotransmitter. Because dopamine re-
lease in limbic and cortical structures is considered to play an
importantroleintherewardingaspectsofseveraldrugsofabuse,
including marijuana (Gardner, 2002; Tanda and Goldberg,
2003), the current findings provide further insight into the man-
ner in which marijuana exerts its reinforcing effects.
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